Aspiriant LLC’s Texas Instruments TXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$477K Buy
1,704
+133
+8% +$36.8K 0.01% 251
2026
Q2
$468K Buy
1,571
+451
+40% +$125K 0.01% 256
2026
Q1
$217K Buy
+1,120
New +$227K 0.01% 325
2025
Q1
– Sell
-1,548
Closed -$290K – 305
2024
Q4
$290K Buy
1,548
+129
+9% +$25.8K 0.01% 238
2024
Q3
$293K Buy
1,419
+200
+16% +$40.2K 0.01% 235
2024
Q2
$237K Sell
1,219
-491
-29% -$90.7K 0.01% 258
2024
Q1
$298K Buy
1,710
+165
+11% +$27.5K 0.01% 248
2023
Q4
$263K Buy
+1,545
New +$239K 0.01% 258
2022
Q1
– Sell
-1,477
Closed -$279K – 300
2021
Q4
$279K Buy
1,477
+223
+18% +$42.8K 0.01% 235
2021
Q3
$240K Sell
1,254
-18
-1% -$3.43K 0.01% 214
2021
Q2
$245K Buy
+1,272
New +$238K 0.01% 213
2020
Q4
– Sell
-4,351
Closed -$622K – 223
2020
Q3
$622K Buy
+4,351
New +$591K 0.05% 138

Other funds holding TXN

Aspiriant LLC's TXN Position: Q3 2026 in Review

Aspiriant LLC increased its Texas Instruments (TXN) stake by 8.5% in Q3 2026, buying an estimated $36.8K and bringing the position to 1,704 shares worth $477K. The position accounts for 0.01% of the portfolio, ranked #251.

Aspiriant LLC first reported a position in TXN in Q3 2020 and has held it in 12 quarters since. The position peaked at $622K in Q3 2020. 2,196 funds tracked by Wall St. Rank hold TXN as of Q3 2026.

  • Aspiriant LLC held 1,704 shares of Texas Instruments worth $477K as of Q3 2026.
  • Aspiriant LLC bought 133 Texas Instruments shares in Q3 2026, an estimated $36.8K.
  • Texas Instruments made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #251 holding.
  • Aspiriant LLC first reported a position in Texas Instruments in Q3 2020 and has held it in 12 quarters since.
  • Aspiriant LLC's Texas Instruments position peaked at $622K in Q3 2020.
  • 2,196 funds tracked by Wall St. Rank held Texas Instruments as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.